1ZU Stock Chart & Stats
€34.80
€0.80(2.35%)
At close: 4:00 PM EDT
€34.80
€0.80(2.35%)
Day’s Range― - ―
52-Week Range€18.50 - €36.60
Previous CloseN/A
Volume0.00
Average Volume (3M)3.00
Market Cap
€1.22B
Enterprise Value€1.58K
Total Cash (Recent Filing)€15.27M
Total Debt (Recent Filing)€493.92M
Price to Earnings (P/E)45.3
Beta0.36
Next Earnings
Nov 09, 2026EPS Estimate
0.3Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.94
Shares Outstanding34,767,555
10 Day Avg. Volume0
30 Day Avg. Volume3
Financial Highlights & Ratios
PEG Ratio1.68
Price to Book (P/B)2.93
Price to Sales (P/S)1.03
P/FCF Ratio37.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
€36.63Price Target Upside5.26% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering5
EPS Forecast (FY)1.19
Revenue Forecast (FY)€1.02B
Bulls Say, Bears Say
Bulls Say
Revenue & EBITDA GrowthSustained double-digit revenue and EBITDA expansion reflects scalable demand for post-acute services and effective integration of acquisitions. Durable top-line and margin growth provide capacity to reinvest in operations, fund integrations and support deleveraging if sustained over multiple quarters.
Home Health & Hospice Volume And Same-Store MarginMaterial volume gains and same-store margin improvement indicate durable organic demand and operational leverage in core services. Higher Medicare admissions and margin expansion suggest sustainable reimbursement and efficiency gains that support long-term cash generation in the company's primary revenue pool.
Leadership & M&A ExecutionA deeper leadership bench and proven M&A track record are structural advantages for integrating acquired operations and scaling standardized clinical and operating models. Strong management depth reduces execution risk and supports repeatable consolidation in a fragmented post-acute market.
Bears Say
Meaningful LeverageMaterial leverage increases sensitivity to interest rates and cash-flow swings in a sector exposed to reimbursement and occupancy volatility. Even with improvement versus earlier years, debt above equity and sizeable outstanding credit lines constrain strategic flexibility and raise refinancing risk during adverse cycles.
Weakening Cash ConversionA sharp drop in free cash flow limits internal funding for CapEx, integration and debt paydown, increasing reliance on credit. Persistently weaker cash conversion can pressure liquidity, slow deleveraging and force trade-offs between investment in growth and maintaining financial resilience.
Integration & EMR Transition RiskLarge-scale integrations and EMR migrations create sustained operational disruption risks, higher TSA and transition costs, and near-term margin compression. If execution lags, occupancy and revenue normalization may be delayed, reducing expected synergies and extending pressure on cash flow and margins.
Pennant Group News
1ZU FAQ
What was Pennant Group Inc’s price range in the past 12 months?
Pennant Group Inc lowest stock price was €18.50 and its highest was €36.60 in the past 12 months.
What is Pennant Group Inc’s market cap?
Pennant Group Inc’s market cap is €1.22B.
When is Pennant Group Inc’s upcoming earnings report date?
Pennant Group Inc’s upcoming earnings report date is Nov 09, 2026 which is in 95 days.
How were Pennant Group Inc’s earnings last quarter?
Pennant Group Inc released its earnings results on Aug 05, 2026. The company reported €0.312 earnings per share for the quarter, beating the consensus estimate of €0.287 by €0.024.
Is Pennant Group Inc overvalued?
According to Wall Street analysts Pennant Group Inc’s price is currently Undervalued.
Does Pennant Group Inc pay dividends?
Pennant Group Inc does not currently pay dividends.
What is Pennant Group Inc’s EPS estimate?
Pennant Group Inc’s EPS estimate is 0.3.
How many shares outstanding does Pennant Group Inc have?
Pennant Group Inc has 34,767,555 shares outstanding.
What happened to Pennant Group Inc’s price movement after its last earnings report?
Pennant Group Inc reported an EPS of €0.312 in its last earnings report, beating expectations of €0.287. Following the earnings report the stock price went same N/A.
Which hedge fund is a major shareholder of Pennant Group Inc?
Currently, no hedge funds are holding shares in DE:1ZU
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Pennant Group Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
€36.63 (5.26% Upside)
€36.63 (5.26% Upside)
Blogger Sentiment
Bullish
DE:1ZU Sentiment 100%
Sector Average ―
Sector Average ―
Insider Transactions
Sold Shares
Worth €248.7K over
the Last 3 Months
the Last 3 Months
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
77.04%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
28.62%
Trailing 12-Months
Company Description
Pennant Group Inc
The Pennant Group, Inc. is a U.S.-based healthcare provider, delivering a diverse range of services through two core divisions: Home Health and Hospice Services, and Senior Living Services. The company's Home Health segment offers in-home clinical support, encompassing nursing, speech, occupational, and physical therapy, as well as medical social work and home health aide assistance. Its Hospice services focus on providing comprehensive clinical care, education, and counseling to meet the physical, spiritual, and psychosocial needs of terminally ill patients and their families. In its Senior Living division, Pennant provides residential accommodations, organized activities, meals, housekeeping, and aid with daily living tasks for seniors who are either independent or require some support. As of December 31, 2021, the company's extensive operational footprint included 88 home health and hospice agencies and 54 senior living communities, collectively featuring 4,127 senior living units. These facilities are located across Arizona, California, Colorado, Idaho, Iowa, Montana, Nevada, Oklahoma, Oregon, Texas, Utah, Washington, Wisconsin, and Wyoming. The Pennant Group, Inc. was established in 2019 and maintains its corporate headquarters in Eagle, Idaho.
1ZU Earnings Call
Q2 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call communicated strong top-line and margin progress driven by substantial acquisitional growth, robust Home Health & Hospice volume expansion, meaningful same-store margin improvements and active Senior Living M&A, backed by a strengthened leadership pipeline. At the same time, management emphasized near-term integration costs and operational disruption from EMR transitions, TSA expenses, labor and occupancy volatility tied to recent acquisitions, and modest liquidity constraints. Overall the positives (strong revenue and EBITDA growth, meaningful same-store improvement, admissions/census gains and disciplined M&A execution) outweigh the transitory integration and reimbursement headwinds, but the company remains cautious while completing large-scale integrations.View all DE:1ZU earnings summaries1ZU Stock 12 Month Forecast
Average Price Target
€36.63
▲(5.26% Upside)
Technical Analysis
AMN Healthcare Services
―
Healthcare Services
―
―
US Physical Therapy
―
Astrana Health
―










